Search
for
Sort by
Research 151–180 of 431
- Oral Manifestations of Hematologic and Nutritional Diseases
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Reversible Alopecia Universalis During Treatment with PEG-Interferon and Ribavirin for Chronic Hepatitis C
- Adverse Drug Reactions in HIV/AIDS Patients on Highly Active Antiretro Viral Therapy: A Review of Prevalence
- The Influence of Various Parameters on the Success of Sensor-Controlled Scalp Cooling in Preventing Chemotherapy-Induced Alopecia
- Congenital atrichia and hypotrichosis
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Imported cutaneous Leishmaniasis in Japan
- Alopecia Areata
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Concomitant acute alopecia and profound bone marrow suppression: An unusual manifestation of azathioprine toxicity
- Mixing the Old with the New: Drug Repurposing for Immune Deficiency in the Era of Precision Medicine and Pediatric Genomics
- Tricotiodistrofia. Reporte de un caso
- Lupus erythematosus: systemic and cutaneous manifestations
- Cell Types Promoting Goosebumps Form a Niche to Regulate Hair Follicle Stem Cells
- Standardizing the 60-Second Hair Count
- TLR2 regulates hair follicle cycle and regeneration via BMP signaling
- Use of modern technological devices (photography, mobile phone applications and artificial intelligence) in dermatology
- Use of chemotherapy during human pregnancy
- Deletion of the Developmentally Essential Gene ATR in Adult Mice Leads to Age-Related Phenotypes and Stem Cell Loss
- Severe cutaneous adverse reactions to drugs
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Medical Treatment of Liver Hydatidosis
- Cutaneous reactions to recombinant cytokine therapy
- No evidence for the immunocompetence handicap hypothesis in male humans
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study